Rick Soni, President and COO of Rexahn Pharmaceuticals, Talks to Proactiveinvestors

Rick Soni, President and COO of Rexahn Pharmaceuticals, talks about a strong positive signal that Serdaxin can work as an anti-depressant, a planned Phase 2b trial for this application, a partnership with Teva Pharmaceuticals, Zoraxel as a possible treatment for erectile dysfunction, and Archexins Phase 2 trials for pancreatic cancer.
Video Rating: 5 / 5